Stage 0 Bladder Urothelial Carcinoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Stage 0 Bladder Urothelial Carcinoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT05037279

Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive B…

The aim of this study is to evaluate the effect of Verity-BCG in patients with intermediate and high-risk non-muscle-invasive bladder cancer (NMIBC) and to comp…

Canada540 participantsStarted 2024-04-24

Treatment: Bacillus Calmette-Guerin: Strain Russian BCG-I, Bacillus Calmette-Guerin: Strain TICE

All recent trials (29 shown)

Active — Not RecruitingPhase 3

NCT03091660

S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer

This randomized phase III trial studies Tokyo-172 strain bacillus Calmette-Guerin (BCG) solution with or without a vaccination using Tokyo-172 strain BCG to see…

United States1,000 participantsStarted 2017-02-24

Treatment: BCG Solution, BCG Tokyo-172 Strain Solution

Active — Not RecruitingPhase 1

NCT05768347

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

The purpose of the study is to evaluate the feasibility, safety and tolerability of intravesical adoptive cell therapy using TIL (tumor infiltrating lymphocytes…

United States9 participantsStarted 2023-08-10

Treatment: Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)

Stage 0 Bladder Urothelial Carcinoma

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive B…

All recent trials (29 shown)

S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive B…

All recent trials (29 shown)

S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer

Chemotherapy in Treating Patients With Early-Stage Bladder Cancer

Intravesical BCG: is the Urinary Bladder Ready to Receive it

The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression

Diagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test.

Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Sur…

Talimogene Laherparepvec in Treating Patients With Non-Muscle Invasive Bladder Transitional Cell Carcinoma

S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer

Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer

Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery

Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer

S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmet…

Tipifarnib in Treating Patients With Recurrent Bladder Cancer

Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer

Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer

Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer

Quality of Life in Patients With Bladder Cancer